Etijab Plus 0.25mg/40mg Tablet
By Etijab Plus
Rx
10 Tablet in a Strip

Composition
Etizolam(0.25mg) + Propranolol(40mg)

Manufacturer - Jabs Biotech Pvt Ltd
Street No. 5, Sangatpura, Near Patiala Gate, Nabha

Expires on or after
October, 2025

liver
Etijab Plus 0.25mg/40mg Tablet should be used carefully in patients with liver disease. It may require a dose adjustment, so make sure to consult your doctor before using this medication. Regular monitoring of blood pressure is recommended to help with any necessary dose adjustments.

kidney
Limited information is present about the use of Etijab Plus 0.25mg/40mg Tablet in patients with kidney disease. Kindly consult your doctor regarding this concern.

alcohol
It is not safe to drink alcohol while taking Etijab Plus 0.25mg/40mg Tablet.

driving
When taking Etijab Plus 0.25mg/40mg Tablet, be cautious while driving as it may cause side effects like visual disturbances, hallucinations, fatigue, mental confusion, dizziness, or tiredness. These can affect your ability to drive safely.

pregnancy
Etijab Plus 0.25mg/40mg Tablet is not recommended during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will evaluate the benefits and risks before prescribing. Please consult your doctor before using.

breastfeeding
It is better to consult your doctor before using Etijab Plus 0.25mg/40mg Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹70
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025